Related News
Antiviral therapy can reduce liver cancers
By Cai Wenjun |
December 10, 2012, Monday
|
Online Edition
Online Edition
China accounts for 55 percent of the 500,000 new liver cancer cases reported worldwide each year and 90 percent of the new cases stem from hepatitis B, a medical forum said yesterday.
Antiviral therapy is the most effective treatment for hepatitis B, however many Chinese patients fail to receive proper treatment.
The forum learned that the nation's first health guidance for hepatitis B patients will be issued jointly by the Wu Jieping Medical Association and the US pharmaceutical giant Bristol-Myers Squibb.
"Appropriate antiviral therapy for hepatitis B can delay the deterioration of the disease and reduce the possibility of cirrhosis and liver cancer," said Dr Wei Lai, director of the Chinese Medical Association's liver disease branch.
Currently, there are nearly 30 million hepatitis B patients in China.
Antiviral therapy is the most effective treatment for hepatitis B, however many Chinese patients fail to receive proper treatment.
The forum learned that the nation's first health guidance for hepatitis B patients will be issued jointly by the Wu Jieping Medical Association and the US pharmaceutical giant Bristol-Myers Squibb.
"Appropriate antiviral therapy for hepatitis B can delay the deterioration of the disease and reduce the possibility of cirrhosis and liver cancer," said Dr Wei Lai, director of the Chinese Medical Association's liver disease branch.
Currently, there are nearly 30 million hepatitis B patients in China.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
